Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Credit agrmnt [a]
CC transcript
BARR PHARMACEUTICALS INC (BRL) Create: Alert

All | News | Filings
Date FiledTypeDescription
12/23/2008 8-K Quarterly results
12/23/2008 15-12G Form 15-12G -- Securities registration termination [Section 12(g)]
12/23/2008 25-NSE Form 25-NSE --
12/22/2008 425 Form 425 -- Prospectuses and communications, business combinations
12/22/2008 425 Form 425 -- Prospectuses and communications, business combinations
11/20/2008 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
11/13/2008 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
11/07/2008 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
11/06/2008 10-Q Quarterly Report for the period ended September 30, 2008
11/06/2008 8-K Quarterly results
Docs: "Barr Reports Third Quarter 2008 GAAP Earnings of $0.28 Per Share; Adjusted Earnings of $0.83 Per Share"
11/06/2008 TRN Barr Pharmaceuticals Inc. Q3 2008 Earnings Call Transcript
11/04/2008 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
10/31/2008 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
10/29/2008 8-K Form 8-K -- Current report
10/15/2008 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
10/14/2008 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition
09/10/2008 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
09/02/2008 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
08/13/2008 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
08/08/2008 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
08/07/2008 10-Q Quarterly Report for the period ended June 30, 2008
08/07/2008 TRN Barr Pharmaceuticals, Inc. Q2 2008 Earnings Call Transcript
08/07/2008 8-K Quarterly results
Docs: "Barr Reports Second Quarter 2008 GAAP Earnings of $0.52 Per Share; Adjusted Earnings of $0.64 Per Share"
07/25/2008 SC 13G SAC CAPITAL ADVISORS LLC reports a 3.5% stake in BARR PHARMACEUTICALS, INC.
07/24/2008 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
07/21/2008 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
07/21/2008 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
07/21/2008 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
07/21/2008 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
07/18/2008 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
07/18/2008 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
07/18/2008 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
07/18/2008 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
07/18/2008 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger, among Teva, Boron Acquisition Corp. and the Company",
"JOINT PRESS RELEASE"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy